Description
With an aging population in the United States, the incidence of prevalence of age-related diseases and disorders is expected to mount rapidly over the next decade. Since senior citizens already consume a disproportionate amount of healthcare dollars, the economic picture will only go from bad to worse insofar as healthcare is concerned. The solution to this problem, for this generation and the future, is prevention.
The new emphasis on prevention opens up a scope of opportunity in the alternative care realm, especially with regard to dietary supplements and nutriceuticals. The United States market for nutrition products is well over $60 billion annually – one-third of this being accounted for by the sale of supplements. The combination of supplement and functional food sales accounts for two-thirds of this market. What is important is that companies that, with few exceptions, are little more than “mom and pop” operations achieve these sales without clear clinical support for these products.
This presents a huge opportunity for pharmaceutical and biotechnology companies willing to undertake the effort to educate the medical community and the consumer with regard to the preventive effects of supplement products on age-related disease and disorders with significantly less investment than would be required for ethical pharmaceuticals. Moreover, with the reputation, status, and resources of the pharmaceutical and biotechnology industries addressing the prevention needs of an aging population, it is clear that the market for nutritional products could grow and at accelerated rate for the next ten to twenty years.
Scope
This report focuses on the growth in incidence and prevalence of age-related disorders in the American population, the use of alternative approaches (notably nutritional supplements) in their prevention and treatment, the options that they present, the progress that is being made in these fields and the motivations for broader pharmaceutical industry involvement in these markets. The major market effects of nutritional supplements and other alternative medical practices have the potential to significantly impact the United States healthcare markets over the next ten years, especially in applications in age-related health priorities (e.g., rheumatoid arthritis, Type II diabetes, cardiovascular disease, etc.).
This report covers current alternative medical approaches in a broad sense. It focuses on product-oriented markets, and does not go into the details of exercise, diet, meditation, yoga, and the various devices that are marketed with claims of healthful benefits. This report does discuss, however, the general aspects and impacts of diet and exercise on age-related disease/disorder development and provides a more detailed view of the role of nutritional supplements in the prevention and management of age-related diseases/disorders.
Market analysis for this report considers the various applications of nutritional supplements in the United States and details high-, mid-, and low-range forcasts for natural personal care products, natural/organic foods, functional foods, and nutritional supplements. The focus of the report, however, is on nutritional supplement products with the potential to provide major market opportunities for pharmaceutical companies wishing to enter the field. The supplement market is segmented by six segments: Vitamins, Herbs, Meal Supplements, Specialty Products, Sports Nutritionals, and Minerals.
Methodology
The analysis presented in this report is based on data from a combination of company, government, industry, and institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including nutritionists, internists, geriatricians, research scientists, business development managers and marketing managers.
Table of Contents
Chapter ONe: Executive Summary
- Background
- Scope and Methodology
- Market Size and Growth
- Industry Structure
- Key Strategic Trends
CHAPTER TWO: Demographics of the Aging U.S. Population
- Background
- Population Demographics
- Economic Status of the Older Population
- Medical Expenditures Among the Older Population
CHAPTER THREE: Preventable Medical Problems of Aging
- Overview
- Bone Deterioration and Osteoporosis
- Cancer
- Cardiovascular Problems
- Atherosclerosis
- Hypertension
- Type II Diabetes
- Eye Conditions
- Gastrointestinal Disorders
- Immune Disorders
- Joint Disorders
- Lung Disorders
- Men’s Health Issues
- Mental Acuity Disorders
- Weight Problems and Obesity
- Women’s Health Issues
CHAPTER FOUR: Preventive Measures for the Medical Problems of Aging
- Overview
- Bone Health
- Pharmaceuticals
- Nutrition
- Exercise
- Supplements
- Cancer
- Surveillance and Prevention
- Pharmaceuticals
- Nutrition
- Supplements
- Cardiovascular Health
- Pharmaceuticals
- Nutrition
- Supplements
- Diabetes
- Nutrition
- Pharmaceuticals
- Supplements
- Eye Health
- Pharmaceuticals
- Supplements
- Gastrointestinal Health
- Immune Support and Control
- Exercise
- Nutrition
- Pharmaceuticals
- Supplements
- Joint Health and Support
- Lung Health
- Men’s Health
- Pharmaceuticals
- Supplements
- Mental Acuity and Emotional Health
- Diet and Exercise
- Pharmaceuticals
- Supplements
- Weight Management
- Diet and Exercise
- Supplements
- Women’s Health
CHAPTER FIVE: Products, Market Status, and Opportunities
- The Need
- Market Definition and Regulation
- Market Size
- Applications, Markets, and Opportunities
- Weight Control
- Rheumatoid Arthritis
- Type II Diabetes
- Cardiovascular Diseases
- Mental Acuity and Memory
- Women’s Health
- Men’s Health
- Industry and Competition Characteristics
- The Strategy
CHAPTER SIX: Company Profiles
- Bayer
- Herbalife International of America, Inc.
- Metabolife International, Inc.
- Pharmanex Division of NuSkin Enterprises
- Rexall/Sundown
- Ross Products Division of Abbott
- Laboratories
CHAPTER SEVEN: Conclusions and Strategic Implications
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
- Eighth
- Conclusion
APPENDIX A: Glossary
Appendix B: Company Names and Addresses
L I S T O F E X H I B I T S
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: Increasing Median Age of the United States Population
- Figure 1-2: Increasing Mean Age of the United States Population
- Figure 1-3: Projected United Stated Market Trends for Nutritional and Natural Personal Health Products by Low-, Mid- and High-Range Estimates: 2004 – 2014
- Figure 1-4: Projected United Stated Market Trends for Nutritional Supplement Products by Low-, Mid- and High-Range Estimates: 2004 – 2014
CHAPTER TWO: DEMOGRAPHICS OF THE AGING U.S. POPULATION
- Figure 2-1: Age-Related Disorders Suffered by Americans 35 Years of Age and Older: 2003
- Figure 2-2: Prevalence Distribution of Selected Age-Related Conditions by Age Group: 2003
- Figure 2-3: Growth of the World’s Elderly (60+ Years) Population 2001- 2025
- Figure 2-4: Population Distribution of the United States by Age and Sex for 1999 and 2025
- Figure 2-5: The Growing United States Population: 2003-2013
- Figure 2-6: Increasing Median Age of the United States Population
- Figure 2-7: Increasing Mean Age of the United States Population
- Table 2-1: Aging of the United States Population in the Age Groups Years and Older: 2003-2013 (Population in Millions)
- Figure 2-8: Aging Trends in the United States Population for the Age Groups 45 Years and Older: 2003-2013
- Figure 2-9: Changes in the Composition of the 45 Year-Old and Older Age Segment in the United States: 2003 and 2013
- Figure 2-10: Aging Trends by Percentage of the United States Population for the Age Groups 45 Years and Older: 2003-2013
- Table 2-2: Older Population Groups as Percentages of the Total United States Population by Age Group: 2003-2013 (Percent)
- Table 2-3: Marital Status of the United States Population Age 65 and Older by Age Group and Sex: 2002
- Figure 2-11: Income Distribution of the United States Population Age 65 and Over: 1974 – 2001
- Figure 2-12: Percentage of the United States Population Living in Poverty by Age Group 65 Years of Age and Older: 1982 – 2001
- Table 2-4: Median Household Net Worth By Age Group in the United States for Individuals 65 Years of Age and Older: 1984 – 1999
- Figure 2-13: Household Income Distribution in the United States by Age Group of Individuals 65 Years of Age and Older: 2000
- Table 2-5: Average Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older, in 1999 Dollars, by Age Group: 1992 – 1999
- Figure 2-14: Distribution of Medicare Expenditures by Age Group: 1992 and 1999
- Figure 2-15: The Ratio of Average Healthcare Expenditures by Age Group to the Average Healthcare Expenditures for the Group of Individuals 65 Years of Age and Older as a Whole: 1992 – 1999
- Table 2-6: Percentage of Healthcare Expenditures Incurred by Medicare Beneficiaries Age 65 or Older by Level of Expenditures: 1999
- Table 2-7: Distribution of Healthcare Expenditures Among Medicare Beneficiaries Age 65 and Older by Institutional Status: 1999
- Table 2-8: Components of Healthcare Expenditures: 1992 and 1999
- Table 2-9: Percentage Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Age Group: 1999
- Table 2-10: Dollar Value Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Age Group: 1999
- Figure 2-16: Trending in the Percentage Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Age Group: 1999
- Figure 2-17: Trending in the Dollar Value Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Age Group: 1999
- Table 2-11: Percentage Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Income Level: 1999
- Figure 2-18: Trending in the Percentage Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Income Level: 1999
- Table 2-12: Dollar Value Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Income Level: 1999
- Figure 2-19: Trending in the Dollar Value Distribution of Major Components of Healthcare Expenditures Among Medicare Beneficiaries Age 65 or Older by Income Level: 1999
CHAPTER THREE: PREVENTABLE MEDICAL PROBLEMS OF AGING
- Table 3-1: Types of Osteoporosis (Description, Contributing Factors)
- Table 3-2: Common Avoidable Environmental Factors in the Prevention of Cancer
CHAPTER FOUR: PREVENTIVE MEASURES FOR THE MEDICAL PROBLEMS OF AGING
- Table 4-1: Dietary Supplements on the United States Market (Name, Description, and Health Claims)
- Table 4-2: Pharmaceuticals for the Prevention of Osteoporosis
- Table 4-3: Supplements Claimed to Beneficial in Bone Health
- Table 4-4: Supplements Claimed to Beneficial in Cancer Prevention
- Table 4-5: Commonly Used Anti-Lipemic Agents on the Market for the Treatment of Dyslipidemia
- Table 4-6: Supplements Claimed to Beneficial in Cardiovascular Disease Prevention
- Table 4-7: Supplements Claimed to Beneficial in Diabetes/Diabetic Complications Prevention
- Table 4-8: Supplements Claimed to Beneficial in Cataract and Age-Related Maculat Degeneration Prevention
- Table 4-9: Supplements Claimed to Beneficial in Gastrointestinal Health
- Table 4-10: Supplements Claimed to Beneficial in Immune System Support
- Table 4-11: Supplements Claimed to Beneficial in Joint Health Support
- Table 4-12: Supplements Claimed to Beneficial in Lung Health Support
- Table 4-13: Pharmaceutical Products for Erectile Dysfunction
- Table 4-14: Supplements Claimed to Beneficial in Men’s Health Support
- Table 4-15: Supplements Claimed to Beneficial in Mental Health Support
- Table 4-16: Energy, Exercise and Dietary Equivalents
- Table 4-17: Supplements Claimed to Beneficial in Weight Loss and Control
- Table 4-18: Pharmaceutical Products for Hormone Replacement Therapy
- Table 4-19: Supplements Claimed to Beneficial in Menopause and PMS
CHAPTER FIVE: PRODUCTS, MARKET STATUS, AND OPPORTUNITIES
- Table 5-1: Projected U.S. National Healthcare Expenditures by Type (Services, Supplies, Personal Hospital, Professional Services, Physician and Clinical, Dental, NursingCare, Home Care, Nursing Homes, Retail Products, Rx Drugs, Durable Equipment, Non-Durable Equipment, and Others) 2004 – 2014
- Figure 5-1: Projected Increases in United States Healthcare Costs in Billions of Dollars and as a Percentage of Gross Domestic Product 2004 – 2014
- Table 5-2: Projected United Stated Market for Nutritional and Natural Personal Health Products by Type (Functional Foods, Supplements, Natural & Organic Foods, and Natural Personal Care Products) 2004 – 2014
- Figure 5-2: Projected United Stated Market Trends for Nutritional and Natural Personal Health Products by Low-, Mid- and High-Range Estimates: 2004 – 2014
- Figure 5-3: Projected United Stated Market Trends in Dollars for Nutritional and Natural Personal Health Products by Product Category: Low-Range Estimates, 2004 – 2014
- Figure 5-4: Projected United Stated Market Trends by Percent Composition for Nutritional and Natural Personal Health Products by Product Category: Low-Range Estimates, 2004 – 2014
- Figure 5-5: Projected United Stated Market Trends in Dollars for Nutritional and Natural Personal Health Products by Product Category: Mid-Range Estimates, 2004 – 2014
- Figure 5-6: Projected United Stated Market Trends by Percent Composition for Nutritional and Natural Personal Health Products by Product Category: Mid-Range Estimates, 2004 – 2014
- Figure 5-7: Projected United Stated Market Trends in Dollars for Nutritional and Natural Personal Health Products by Product Category: High-Range Estimates, 2004 – 2014
- Figure 5-8: Projected United Stated Market Trends by Percent Composition for Nutritional and Natural Personal Health Products by Product Category: High-Range Estimates, 2004 – 2014
- Table 5-3: Projected United States Nutritional Supplement Markets by Supplement Type (Vitamins, Herbs, Meal Supplements, Specialty Products, Sports Nutrition, and Minerals): 2004 – 2014
- Figure 5-9: Projected United Stated Market Trends for Nutritional Supplement Products by Low-, Mid- and High-Range Estimates: 2004 – 2014
- Figure 5-10: Projected United Stated Market Trends in Dollars for Nutritional Supplement Products by Product Category: Low-Range Estimates, 2004 – 2014
- Figure 5-11: Projected United Stated Market Trends by Percent Composition for Nutritional Supplement Products by Product Category: Low-Range Estimates, 2004 – 2014
- Figure 5-12: Projected United Stated Market Trends in Dollars for Nutritional Supplement Products by Product Category: Mid-Range Estimates, 2004 – 2014
- Figure 5-13: Projected United Stated Market Trends by Percent Composition for Nutritional Supplement Products by Product Category: Mid-Range Estimates, 2004 – 2014
- Figure 5-14: Projected United Stated Market Trends in Dollars for Nutritional Supplement Products by Product Category: High-Range Estimates, 2004 – 2014
- Figure 5-15: Projected United Stated Market Trends by Percent Composition for Nutritional Supplement Products by Product Category: High-Range Estimates, 2004 – 2014
